SO
SIOX

STRS Ohio’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

STRS Ohio’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,138
Closed -$227K – 1952
2017
Q3 		$227K Buy
4,138
+125
+3% +$21.1K ﹤0.01% 1522
2017
Q2 		$744K Sell
4,013
-1,662
-29% -$291K ﹤0.01% 1030
2017
Q1 		$678K Hold
5,675
– – ﹤0.01% 1135
2016
Q4 		$563K Hold
5,675
– – ﹤0.01% 1299
2016
Q3 		$635K Sell
5,675
-425
-7% -$51K ﹤0.01% 1151
2016
Q2 		$626K Buy
6,100
+5,525
+961% +$552K ﹤0.01% 1156
2016
Q1 		$52K Hold
575
– – ﹤0.01% 1757
2015
Q4 		$82K Hold
575
– – ﹤0.01% 1719
2015
Q3 		$59K Buy
+575
New +$67.4K ﹤0.01% 1741

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

STRS Ohio's SIOX Position: Q4 2017 in Review

STRS Ohio sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2017, closing a stake of 4,138 shares — an estimated $227K sold.

STRS Ohio first reported a position in SIOX in Q3 2015 and held it in 9 quarters. The position peaked at $744K in Q2 2017. 104 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

  • STRS Ohio reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • STRS Ohio sold 4,138 Sio Gene Therapies Inc. Common Stock shares in Q4 2017, an estimated $227K.
  • STRS Ohio first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 9 quarters.
  • STRS Ohio's Sio Gene Therapies Inc. Common Stock position peaked at $744K in Q2 2017.
  • 104 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2017.

Based on STRS Ohio's 13F filing for Q4 2017, filed 23 Jan 2018.